These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36572921)

  • 21. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
    Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
    Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
    J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
    Bourillon L; Bourgier C; Gaborit N; Garambois V; Llès E; Zampieri A; Ogier C; Jarlier M; Radosevic-Robin N; Orsetti B; Delpech H; Theillet C; Colombo PE; Azria D; Pèlegrin A; Larbouret C; Chardès T
    Int J Cancer; 2019 Oct; 145(7):1838-1851. PubMed ID: 30882895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies.
    Kang X; Zhou L; Jian YM; Lan SA; Xu F
    Med Sci Monit; 2018 Mar; 24():1408-1416. PubMed ID: 29515096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 26. An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
    Li H; Yu C; Jiang J; Huang C; Yao X; Xu Q; Yu F; Lou L; Fang J
    Cancer Biol Ther; 2016 Apr; 17(4):346-54. PubMed ID: 26853765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monomethyl auristatin E (MMAE), a payload for multiple antibody drug conjugates (ADCs), demonstrates differential red blood cell partitioning across human and animal species.
    Yip V; Saad OM; Leipold D; Li C; Kamath A; Shen BQ
    Xenobiotica; 2024 Aug; 54(8):511-520. PubMed ID: 38647387
    [No Abstract]   [Full Text] [Related]  

  • 28. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.
    Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG
    Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment.
    Chang FL; Lee CC; Tsai KC; Lin TY; Chiang CW; Pan SL; Lee YC
    Biochem Biophys Res Commun; 2023 Dec; 688():149214. PubMed ID: 37951154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET.
    Terwisscha van Scheltinga AG; Ogasawara A; Pacheco G; Vanderbilt AN; Tinianow JN; Gupta N; Li D; Firestein R; Marik J; Scales SJ; Williams SP
    Mol Cancer Ther; 2017 Jan; 16(1):134-142. PubMed ID: 27760836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.
    Yao X; Jiang J; Wang X; Huang C; Li D; Xie K; Xu Q; Li H; Li Z; Lou L; Fang J
    Breast Cancer Res Treat; 2015 Aug; 153(1):123-33. PubMed ID: 26253944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE.
    Suthe SR; Yao HP; Weng TH; Hu CY; Feng L; Wu ZG; Wang MH
    Mol Cancer Ther; 2018 Dec; 17(12):2654-2664. PubMed ID: 30275241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells.
    Damiani I; Castiglioni S; Sochaj-Gregorczyk A; Bonacina F; Colombo I; Rusconi V; Otlewski J; Corsini A; Bellosta S
    Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34439990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
    Buckel L; Savariar EN; Crisp JL; Jones KA; Hicks AM; Scanderbeg DJ; Nguyen QT; Sicklick JK; Lowy AM; Tsien RY; Advani SJ
    Cancer Res; 2015 Apr; 75(7):1376-1387. PubMed ID: 25681274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma.
    Uchida S; Serada S; Suzuki Y; Funajima E; Kitakami K; Dobashi K; Tamatani S; Sato Y; Beppu T; Ogasawara K; Naka T
    Neoplasia; 2024 Apr; 50():100982. PubMed ID: 38417223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies.
    Almhanna K; Prithviraj GK; Veiby P; Kalebic T
    Pharmacol Ther; 2017 Feb; 170():8-13. PubMed ID: 27765652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer.
    Harel ET; Drake PM; Barfield RM; Lui I; Farr-Jones S; Van't Veer L; Gartner ZJ; Green EM; Lourenço AL; Cheng Y; Hann BC; Rabuka D; Craik CS
    Antibodies (Basel); 2019 Nov; 8(4):. PubMed ID: 31694242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models.
    Yu L; Yao Y; Wang Y; Zhou S; Lai Q; Lu Y; Liu Y; Zhang R; Wang R; Liu C; Gou L; Chen X; Yu Y; Chen Q; Yang J
    J Drug Target; 2018 Dec; 26(10):905-912. PubMed ID: 29630426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer.
    Xu C; Zhu M; Wang Q; Cui J; Huang Y; Huang X; Huang J; Gai J; Li G; Qiao P; Zeng X; Ju D; Wan Y; Zhang X
    J Nanobiotechnology; 2023 Nov; 21(1):410. PubMed ID: 37932752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates.
    Hu X; Jiang H; Bai W; Liu X; Miao Q; Wang L; Jin J; Cui A; Liu R; Li Z
    Eur J Med Chem; 2021 Apr; 216():113297. PubMed ID: 33677351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.